-
Recent Posts
- December 01 2013 – Human stem cells converted to functional lung cells
- November 30 2013 – Keyhole lung transplant performed on 60-year-old in Chennai
- November 27 2013 – FibroGen Announces Observations of Possible Disease Stabilization and Improvement in Interim Analysis of Phase 2 Study of FG-3019
- November 15 2013 – Enzo Biochem Announces Study in Leading Scientific Journal Linking Idiopathic Pulmonary Fibrosis, a Deadly Human Disease with No Effective Treatment Options, to Presence of a Monkey Virus
- November 10 2013 – Research by Saint Louis University scientists offers way to disrupt fibrosis
Recent Comments
- Fish With Captain Frank on June 20 2012 MicroDose Therapeutx and Moerae Matrix Announce Collaboration to Develop Novel Inhaled Treatment for Idiopathic Pulmonary Fibrosis (IPF)
- Raymond on June 9 2011 – Ascend Trial – Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Johng182 on InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study
- Johnf73 on InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study
- extreme rush on June 28 2012 Grasping at Straws while Gasping for Air
Archives
Categories
Meta
Monthly Archives: February 2012
February 13 2012 STX-100 – Pulmonary Fibrosis Drug – One Of The VCs Behind Today’s Big Biotech Deal Tells His Story
Biogen just announced its acquisition of Stromedix for up to $562M. Another solid M&A exit in biotech emphasizing how innovation matters. With a very different model than Avila Therapeutics, an exit we announced in January, Stromedix is a biology-focused, asset-centric company … Continue reading
January 20 2012 Carolus Therapeutics Reports Publication of Preclinical Data for CT-2009 Supporting Development in Acute Lung Injury
SAN DIEGO, Jan. 20, 2012 /PRNewswire via COMTEX/ — Carolus Therapeutics, Inc. today announced the publication of preclinical data showing that CT-2009 disrupts heteromers formed by the platelet-derived chemokines CCL5 (RANTES) and CXCL4, thereby preventing lung damage in multiple mouse … Continue reading
January 12 2012 Pacific Therapeutics Ltd. Provides Update on the Development of Lead Drug Candidate PTL-202
Vancouver, British Columbia CANADA, January 12, 2012 /FSC/ – Pacific Therapeutics Ltd. (PT – CNSX)(the “Issuer”) is a development stage specialty pharmaceutical company focused on the identification and development of drug candidates to treat diseases of excessive scarring (fibrosis). Mr. Doug … Continue reading
January 6 2012 Statins may increase risk of interstitial lung abnormalities in smokers
Use of statins may influence susceptibility to or the progression of interstitial lung disease (ILD) in smokers, according to a new study. While some studies have suggested that statins might be beneficial in the treatment of fibrotic lung disease, others … Continue reading
December 22 2011 Coalition for Pulmonary Fibrosis Kicks Off “Lips for a Cure” Promotional Campaign With Mary Kay Products
CULVER CITY, Calif., Dec. 22, 2011 /PRNewswire-USNewswire/ — The Coalition for Pulmonary Fibrosis (CPF) announced today the launch of the first campaign to raise funds for Pulmonary Fibrosis (PF) while paying tribute to a Mary Kay independent sales director who … Continue reading
December 15 2011 IQWIG Publishes Early Benefit Assessment for Pirfenidone
BERLIN, Dec. 15, 2011 /PRNewswire via COMTEX/ — InterMune, Inc. today reported that the private Institute for Quality and Efficiency in Health Care (IQWiG) has today published its report on the benefit assessment of Esbriet® (pirfenidone) for the treatment of … Continue reading
December 14 2011 Pacific Therapeutics Ltd. Announces Closing of Non-Brokered Private Placement
VANCOUVER, BRITISH COLUMBIA–(Marketwire – Dec. 14, 2011) – Mr. Doug Unwin, President and CEO of Pacific Therapeutics Ltd. (the “Issuer”) (CNSX:PT) is pleased to announce the completion of the previously announced non-brokered private placement. The Issuer sold to 357,142 common … Continue reading
December 13 2011 Woman received lung transplant through new UMD procedure
Susan Dunnett’s emphysema made it nearly impossible for her to do anything. It would take the 65-year-old up to 40 minutes to get up the steps and it as long as 20 minutes to get out of bed. “I just … Continue reading
December 12 2011 Stanford-researchers reveal how mechanical forces contribute to scarring
When you get a cut, fibrous connective tissue replaces normal skin, sometimes leaving a visible scar. This process is called fibrosis, and it’s a normal part of the healing process. But sometimes scar formation can be dangerous, disfiguring or just unsightly. … Continue reading
December 6 2011 Pulmonary Fibrosis Foundation’s Inaugural IPF Summit Receives High Accolades From Pulmonary Fibrosis Community
CHICAGO, Dec. 6, 2011 /PRNewswire via COMTEX/ — The Pulmonary Fibrosis Foundation’s (PFF) inaugural conference on idiopathic pulmonary fibrosis (IPF), IPF Summit 2011: From Bench to Bedside, was recently held in Chicago. The event brought together medical professionals, patients, and … Continue reading
